The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 25497965 |
70 |
Synthesis and biological evaluation of novel chiral diazepine derivatives as bombesin receptor subtype-3 (BRS-3) agonists incorporating an antedrug approach. |
Daiichi Sankyo |
| 24412111 |
70 |
Discovery of novel chiral diazepines as bombesin receptor subtype-3 (BRS-3) agonists with low brain penetration. |
Daiichi Sankyo |
| 24900283 |
80 |
Discovery of benzodiazepine sulfonamide-based bombesin receptor subtype 3 agonists and their unusual chirality. |
TBA |
| 24900461 |
49 |
Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity. |
TBA |
| 22494842 |
18 |
The design and synthesis of potent, selective benzodiazepine sulfonamide bombesin receptor subtype 3 (BRS-3) agonists with an increased barrier of atropisomerization. |
Merck Research Laboratories |
| 20371178 |
72 |
Synthesis of 7-benzyl-5-(piperidin-1-yl)-6,7,8,9-tetrahydro-3H-pyrazolo[3,4-c][2,7]naphthyridin-1-ylamine and its analogs as bombesin receptor subtype-3 agonists. |
Amri |
| 21354793 |
100 |
Pyridinesulfonylureas and pyridinesulfonamides as selective bombesin receptor subtype-3 (BRS-3) agonists. |
Merck Research Laboratories |
| 24900253 |
28 |
Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity |
TBA |
| 20347296 |
49 |
Synthesis and SAR of heterocyclic carboxylic acid isosteres based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity. |
Amri |
| 20219372 |
114 |
Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity. |
Merck Research Laboratories |
| 20167483 |
90 |
Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonists. |
Merck Research Laboratories |
| 18818070 |
28 |
Discovery of small molecule agonists for the bombesin receptor subtype 3 (BRS-3) based on an omeprazole lead. |
Glaxosmithkline |
| 15634004 |
20 |
Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study. |
National Center For Scientific Research Demokritos |
| 12723954 |
47 |
Design of selective peptidomimetic agonists for the human orphan receptor BRS-3. |
Technische UniversitäT MüNchen |
| 26914186 |
3 |
Arylazolyl(azinyl)thioacetanilides: Part 19: Discovery of Novel Substituted Imidazo[4,5-b]pyridin-2-ylthioacetanilides as Potent HIV NNRTIs Via a Structure-based Bioisosterism Approach. |
Shandong University |
Search and Browse
